Elsevier Inc.

SHERPA: Unknown

People

  1. Devlin
    Devlin
  2. Giralt
    Giralt
  3. Landau
    Landau
  4. Hassoun
    Hassoun
  5. Lesokhin
    Lesokhin
  6. Chung
    Chung
  7. Shah
    Shah
  8. Koehne
    Koehne
  9. Lendvai
    Lendvai
  10. Mailankody
    Mailankody

Groups

  1. Biostatistics Service (25)
  2. Center for Hematologic Malignancies (25)
  3. Department of Medicine (25)
  4. Epidemiology and Biostatistics (25)
  5. Hematologic Malignancies Research (25)
  6. Hematologic Malignancies, Division of (25)
  7. Bone Marrow Transplant (24)
  8. Survivorship Research (23)
  9. Myeloma (18)
  10. CTCR Scholars (12)
Search Within
  1. "Hematologic Malignancies Research"
  2. "Sean Devlin"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (5)
Groups
  1. Biostatistics Service (25)
  2. Center for Hematologic Malignancies (25)
  3. Department of Medicine (25)
  4. Epidemiology and Biostatistics (25)
  5. Hematologic Malignancies Research (25)
  6. Hematologic Malignancies, Division of (25)

More Groups

People
  1. Sean Devlin (25)
  2. Sergio Giralt (23)
  3. David Chung (18)
  4. Heather Landau (18)
  5. Hani Hassoun (17)
  6. Alexander Lesokhin (16)

More People

Years
  1. 2023 (4)
  2. 2020 (5)
  3. 2019 (1)
  4. 2018 (1)
  5. 2017 (5)
  6. 2016 (3)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (17)
  2. Clinical Lymphoma, Myeloma and Leukemia (8)

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Flynn, J.; Costa, B.; Devlin, S.; Farzana, T.; Nath, K.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Vitamin D deficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Flynn, J.; Costa, B.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Prognostic impact of corticosteroid and tocilizumab use on the efficacy of chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Flynn, J.; Nath, K.; Nishimura, N.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft minimal residual disease negativity with novel induction regimens in multiple myeloma
    Journal Article

    Bal, S.; Landau, H. J.; Shah, G. L.; Scordo, M.; Dahi, P.; Lahoud, O. B.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Prospective identification of unrelated donors with low inhibitory donor KIR3DL1- Recipient HLA-B interaction decreases relapse and improves survival after allogeneic hematopoietic cell transplantation for myeloid neoplasia
    Meeting Abstract

    Shaffer, B. C.; Park, S.; Le Luduec, J. B.; Devlin, S. M.; Jakubowski, A. A.; Gyurkocza, B.; Papadopoulos, E. B.; Tamari, R.; Giralt, S. A.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Hematopoietic recovery following chimeric antigen receptor T cell (CAR T) therapy in hematological malignancies
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; Mead, E.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Pilot study of bortezomib and dexamethasone pre- and post-risk-adapted autologous stem cell transplantation in AL amyloidosis
    Journal Article

    Landau, H.; Lahoud, O.; Devlin, S.; Lendvai, N.; Chung, D. J.; Dogan, A.; Landgren, C. O.; Giralt, S.; Hassoun, H.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation (dCBT) supplemented with haplo-identical CD34+ cells may be associated with enhanced neutrophil recovery but successful myeloid bridging is strongly influenced by haplo CD34+ cell dose and haplo-winning CB unit HLA-match
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M. A.; Naputo, K.; Afuye, A.; Avecilla, S. T.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save